About Amiran

Dr. Amiran Gamkrelidze has been currently working on a position of a Director General of the National Center for Disease Control and Public Health of Georgia since 2013. He is a professor of the School of Sciences and Public Health at the University of Georgia and a visiting professor (on Global Health) at the Tromso University (Norway) / Department of Medicine since 2005; a visiting professor at the International Public Health School of the Tbilisi State Medical University since 2008; has been a scientific advisor at the Center of Allergology and Immunology since 2005 and a Chair of Allergy and Immunology Alliance since 1990. In 2005-2013 Dr. Gamkrelidze worked as a Country Program Coordinator for the WHO Country office in Georgia; in 2001-2004 was a Minister of Labour, Health and Social Affairs; in 1997-2001 was a first Deputy Minister of Labour, Health and Social Affairs; in 1995-1997 Dr. Gamkrelidze worked as a Director of the National Healthcare Management Center and acted as a Deputy Minister of Health; was a Head of Department of Immunogenetics and Epidemiology of allergic diseases at the Institute of Clinical and Experimental Medicine in 1988-1996; a researcher at the Department of Pediatrics of the University of Linkoping, Sweden in 1987-1988; in 1982-1990 was a visiting researcher at the Institute of Clinical Immunology of Freidrich Schiller University, Jena, Germany; assistant professor, associate professor and a full professor of Department of Allergology at the Tbilisi State Medical Institute in 1974-2001. 
Dr. Gamkrelidze’s featured research experience accounts for more than 40 years; Since 1996 Prof. Gamkrelidze has been participating as a permanent member on a regular basis in WHO WHA, RCs, Regional retreats and various expert meetings; as well as an inviting key-note speaker in a number of International and National Congresses, Conferences, workshops and Universities, on Global and Public Health, in Allergy, Clinical Immunology, Asthma and Respiratory Diseases (UK, USA, Sweden, France, Norway etc.); was a member of the WHO European Advisory Committee for Health Research (EACHR), currently a member  WHO SCRC / Euro; also known his expert activities in elaboration of the new European policy Health 2020; is a member of the Editorial Boards of Journals: World Allergy Organization Journal, Allergo Journal (Germany), Georgian Medical News, Georgian Respiratory Journal; Member of the European Academy of Allergy and Clinical Immunology, German Association of Allergology and Clinical Immunology, Board of Georgian Association of Allergology and Clinical Immunology; member of working group of WHO Global Coordination Mechanism on the Prevention and Control of NCDs; an author and a co-author of 150 publications.

This speaker will be presenting at the following session(s)

  • The critical role of strategic information : HCV elimination in Georgia

    Parallel workshop

    Day: 1 November

    Time: 15:30

    Chair: Dr. Francisco Averhoff, US Centers for Disease Control and Prevention

    Chair: Dr. Helen Harris, Public Health England

    Presentations:

    • Assessing the burden of disease: the planning, conduct and use of a National Seroprevalence Survey.
    • Dr. Amiran Gamkrelidze, National Center for Disease Control and Public Health of Georgia
    • Monitoring the care cascade: developing a robust screening and treatment information system.
    • Dr. Lia Gvinjilia, CDC Foundation
    • The role of research and project monitoring in HCV elimination.
    • Dr. Tinatin Kuchuloria, CDC Foundation
    • Modelling the epidemic to guide interventions.
    • Professor Peter Vickerman, University of Bristol
    • Project oversight and guidance: the role of an independent Technical Advisory Group (TAG).
    • Dr. Muazzam Nasrullah, US Centers for Disease Control and Prevention

    Session objectives:

    • Learn the importance of a well conducted population serosurvey to guide development of an evidence-based national strategy/plan.
    • Understand the importance of a robust strategic information system to guide and monitor an elimination program.
    • Learn the key role of partnerships in developing a world class information system.
  • Testing interventions

    Parallel workshop

    Day: 2 November

    Time: 11:30

    Presentations:

    • WHO testing guidelines.
    • Professor Philippa Easterbrook, World Health Organization
    • Overview of rapid assays for viral hepatitis agents: what test for what setting?
    • Dr. Saleem Kamili, US Centers for Disease Control and Prevention
    • Are screening campaigns feasible and acceptable: the PROLIFICA experience.
    • The national strategic plan in Georgia.
    • Dr. Amiran Gamkrelidze, National Center for Disease Control and Public Health of Georgia

    Session objectives:

    • Review the scientific, logistical, ethical and political process leading to the implementation of state-of-the-art testing for viral hepatitis.
    • Discuss the feasibility and validity of diagnostic algorithm simplifications.
    • Define what testing strategies should be applied in different settings.
    • Discuss the preliminary results of testing strategies in selected areas.